Legal Opinion

Mylan Pharmaceuticals, Inc. v. Henney

District Court, District of Columbia

Decided March 31, 2000No. 1:99-cv-00862PublishedCited by 26 opinions

1Opinion of the Court

MEMORANDUM OPINION

URBINA, District Judge.

ORDERING CONSOLIDATION OF CASES; DENYING MYLAN’S AND PHARMACHEMIE’S MOTIONS FOR INJUNCTIVE RELIEF; DENYING MYLAN’S AND PHARMA-CHEMIE’S MOTIONS TO INTERVENE; REMANDING TO FDA FOR PERMISSIBLE INTERPRETATION OF 21 U.S.C. § 355(j)(5)(B)(iv) AND REGULATION 314.94(a)(12)(viii)

I. INTRODUCTION

Pharmachemie, B.V. (“Pharmachemie”) and Mylan Pharmaceuticals, Inc. (“My-lan”), genei'ic manufacturers of the drug tamoxifen (together, the “Parties”), bring separate actions against Defendant Jane E. Henney, M.D., in her official capacity as Commissioner of the United…

2Cases cited72 opinions

  1. Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
  2. Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
  3. Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
  4. Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
  5. Will v. Michigan Department of State PoliceSupreme Court of the United States · 1989

67 more not listed; retrieve them via the Exa API.

3Cited by26 opinions

  1. Joblove v. Barr Labs. Inc.Court of Appeals for the Second Circuit · 2005
  2. Pharmachemie B.V. v. Barr Laboratories, Inc.Court of Appeals for the D.C. Circuit · 2002
  3. In Re Cardizem CD Antitrust LitigationDistrict Court, E.D. Michigan · 2000
  4. In Re Ciprofloxacin Hydrochloride Antitrust LitigationDistrict Court, E.D. New York · 2003
  5. Individual Reference Services Group, Inc. v. Federal Trade CommissionDistrict Court, District of Columbia · 2001

21 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API